These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

666 related items for PubMed ID: 26988593

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study.
    Sokol J, Timp JF, le Cessie S, van Hylckama-Vlieg A, Rosendaal FR, Kubisz P, Cannegieter SC, Lijfering WM.
    J Thromb Haemost; 2018 Apr; 16(4):680-688. PubMed ID: 29377625
    [Abstract] [Full Text] [Related]

  • 26. Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study.
    Enga KF, Rye-Holmboe I, Hald EM, Løchen ML, Mathiesen EB, Njølstad I, Wilsgaard T, Braekkan SK, Hansen JB.
    J Thromb Haemost; 2015 Jan; 13(1):10-6. PubMed ID: 25330989
    [Abstract] [Full Text] [Related]

  • 27. Prothrombin and risk of venous thromboembolism, ischemic heart disease and ischemic cerebrovascular disease in the general population.
    Weischer M, Juul K, Zacho J, Jensen GB, Steffensen R, Schroeder TV, Tybjaerg-Hansen A, Nordestgaard BG.
    Atherosclerosis; 2010 Feb; 208(2):480-3. PubMed ID: 19524925
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Symptomatic perioperative venous thromboembolism is a frequent complication in patients with a history of deep vein thrombosis.
    Liem TK, Huynh TM, Moseley SE, Minjarez RC, Landry GJ, Mitchell EL, Deloughery TG, Moneta GL.
    J Vasc Surg; 2010 Sep; 52(3):651-7. PubMed ID: 20558025
    [Abstract] [Full Text] [Related]

  • 31. Hepatitis C Virus Infection and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis.
    Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Ungprasert P.
    Ann Hepatol; 2017 Sep; 16(4):514-520. PubMed ID: 28611268
    [Abstract] [Full Text] [Related]

  • 32. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
    Luxembourg B, Pavlova A, Geisen C, Spannagl M, Bergmann F, Krause M, Alesci S, Seifried E, Lindhoff-Last E.
    Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Increased risks of venous thromboembolism in patients with psoriasis. A Nationwide Cohort Study.
    Chung WS, Lin CL.
    Thromb Haemost; 2017 Jul 26; 117(8):1637-1643. PubMed ID: 28536717
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study.
    Sode BF, Dahl M, Nielsen SF, Nordestgaard BG.
    Am J Respir Crit Care Med; 2010 May 15; 181(10):1085-92. PubMed ID: 20167844
    [Abstract] [Full Text] [Related]

  • 37. CHI3L1 polymorphisms, cord blood YKL-40 levels and later asthma development.
    Usemann J, Frey U, Mack I, Schmidt A, Gorlanova O, Röösli M, Hartl D, Latzin P.
    BMC Pulm Med; 2016 May 18; 16(1):81. PubMed ID: 27193312
    [Abstract] [Full Text] [Related]

  • 38. Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases.
    Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG.
    Crit Rev Clin Lab Sci; 2016 Dec 18; 53(6):396-408. PubMed ID: 27187575
    [Abstract] [Full Text] [Related]

  • 39. The occurrence of venous thromboembolism in cancer patients following major surgery.
    Toledano TH, Kondal D, Kahn SR, Tagalakis V.
    Thromb Res; 2013 Jan 18; 131(1):e1-5. PubMed ID: 23174626
    [Abstract] [Full Text] [Related]

  • 40. Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
    Bouligand J, Cabaret O, Canonico M, Verstuyft C, Dubert L, Becquemont L, Guiochon-Mantel A, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group.
    Clin Pharmacol Ther; 2011 Jan 18; 89(1):60-4. PubMed ID: 21107315
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.